Ivy Song
Takeda (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Cytomegalovirus and herpesvirus research, HIV/AIDS Research and Interventions, Hepatitis C virus research
Most-Cited Works
- → Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study(2014)325 cited
- → Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial(2011)297 cited
- → Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers(2009)239 cited
- → Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults(2011)213 cited
- → Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin(2012)191 cited
- → A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para‐aminohippurate clearance in healthy subjects(2012)186 cited
- → Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans(2013)136 cited
- → The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects(2016)120 cited
- → Effect of Food on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir(2011)111 cited
- → Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects(2014)102 cited